ROCKVILLE, Md. and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to ...

Shilpa Medicare’s Joint Venture Oncosol along with its partner Shorla Oncology announces that the USFDA has approved IMKELDI ...

Oncosol, along with its partner Shorla Oncology, has received US Food and Drug Administration (USFDA) approval for IMKELDI (imatinib oral solution) to treat leukemia and other cancers.

Shilpa Medicare’s joint venture Oncosol, with Shorla Oncology, has gained US FDA approval for IMKELDI, an imatinib oral ...

Karnataka: Shilpa Medicare's Joint Venture Oncosol (50:50 JV with Liqmeds Lifecare Limited, a Zydus group company and Koana ...

Shilpa Medicare’s equal joint venture with Zydus group - Oncosol - along with its partner company Shorla Oncology, has announced USFDA's approval for IMKELDI, the first oral liquid form of imatinib to ...

The Stanford medical school professor, the expected pick for the top job at the National Institutes of Health, has been a ...

Zai Lab Limited today announced that the 2024 National Reimbursement Drug List (NRDL) released by China's National Healthcare Security Administration (NHSA) has been updated to include the following ...